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UbiquitylationInﬂuenza viruses induce a host shut off mechanism leading to the general inhibition of host gene expression
in infected cells. Here, we report that the large subunit of host RNA polymerase II (Pol II) is degraded in
infected cells and propose that this degradation is mediated by the viral RNA polymerase that associates with
Pol II. We detect increased ubiquitylation of Pol II in infected cells and upon the expression of the viral RNA
polymerase suggesting that the proteasome pathway plays a role in Pol II degradation. Furthermore, we ﬁnd
that expression of the viral RNA polymerase results in the inhibition of Pol II transcription. We propose that
Pol II inhibition and degradation in inﬂuenza virus infected cells could represent a viral strategy to evade
host antiviral defense mechanisms. Our results also suggest a mechanism for the temporal regulation of viral
mRNA synthesis.
© 2009 Elsevier Inc. Open access under CC BY license. Introduction
Viruses have developed a wide range of mechanisms to inhibit the
expression of host genes during the process of virus replication (Lyles,
2000). Although this might provide the virus with higher levels of
cellular resources such as nucleoside triphosphates to be used for the
biosynthesis of viral gene products, it is now believed that the major
role of virus-induced inhibition of host gene expression is to inhibit
antiviral host response. Viruses can interfere with various steps in
host gene expression—transcription, RNA processing and transport,
and translation. For many RNA viruses, the host transcriptional
apparatus represents a logical target for inhibition of host gene
expression as they replicate in the cytoplasm of the host cell without
any obvious requirement for host transcriptional activity. Inﬂuenza
viruses are an exception, since they replicate in the nucleus of the host
cell and require an active host RNA polymerase II (Pol II) (Amorim and
Digard, 2006; Engelhardt and Fodor, 2006). In particular, inﬂuenza
virus cannibalizes host Pol II transcripts to produce RNA fragments
that are needed to initiate viral mRNA synthesis (Bouloy et al., 1978;
Krug et al., 1979). Moreover, ongoing Pol II transcription is required
for the nuclear export of viral mRNAs (Amorim et al., 2007). Therefore
inﬂuenza viruses are absolutely dependent on active transcription by
host Pol II for their replication and indeed, inhibitors of Pol II, i.e. α-
amanitin or actinomycin D, block inﬂuenza virus replication (Lamb
and Choppin, 1977; Mark et al., 1979)..
 license. However, recently our group showed that the inﬂuenza virus RNA
polymerase complex, a heterotrimer of three subunits, polymerase
basic protein 1 (PB1), polymerase basic protein 2 (PB2), and
polymerase acidic protein (PA), binds to the C-terminal domain
(CTD) of the large subunit of initiating Pol II and proposed that this
interaction leads to the inhibition of Pol II activity in inﬂuenza virus
infected cells (Chan et al., 2006; Engelhardt et al., 2005). We
hypothesized that on one hand, hijacking the host transcriptional
machinery might allow the virus to gain access to factors, e.g. capped
RNA fragments, splicing factors, and factors for the assembly of viral
mRNPs, on the other, it could contribute to the inhibition of host gene
expression which inevitably would affect genes involved in antiviral
host responses. Therefore, the ability of the viral RNA polymerase to
inhibit Pol II might be a signiﬁcant factor in viral pathogenesis.
Indeed, the RNA polymerase has been shown to be an important
determinant of inﬂuenza virus pathogenicity (Naffakh et al., 2008).
Several mutations in the RNA polymerase genes have been described
that contribute to the increased pathogenicity of inﬂuenza viruses in
various in vivomodel systems; for example, it is now believed that the
trimeric RNA polymerase complex of the 1918 pandemic strain was a
signiﬁcant contributor to the unusually high pathogenicity associated
with this viral strain (Tumpey et al., 2005; Watanabe et al., 2009). The
RNA polymerase genes were also found to contribute to the high
virulence of the human H5N1 inﬂuenza virus isolates (Salomon et al.,
2006). A more efﬁcient RNA polymerase could lead to viruses with
increased replication potential which could efﬁciently outcompete
and escape the host innate immune responses (Grimm et al., 2007).
However, a more direct role of the viral RNA polymerase in
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RNA polymerase might be involved in virus–host interactions directly
leading to the inhibition of the expression of antiviral host genes or in
a general inhibition of host gene expression.
The association of the viral RNA polymerase with the host Pol II
transcriptional machine is well documented (Engelhardt et al., 2005;
Mayer et al., 2007; Rameix-Welti et al., 2009), but the implications of
this interaction for the functionality of Pol II remain to be understood.
Recently, Rodriguez and colleagues reported that inﬂuenza virus
infection causes a speciﬁc degradation of the large subunit of Pol II and
suggested that the proteolytic activity of the PA subunit of the viral
RNA polymerase was involved (Rodriguez et al., 2007). Here we
investigated the effects of the association between the inﬂuenza virus
RNA polymerase and Pol II on host transcription further. We found
that the binding of the viral RNA polymerase to the initiating form of
Pol II induces its inhibition possibly via triggering ubiquitylation and
proteasome-mediated degradation. We propose that the viral RNA
polymerase-mediated inhibition of Pol II plays an important role in
inhibiting host gene expression and consequently, in inhibiting
antiviral host response. This might have important implications for
viral pathogenesis.
Results
Inﬂuenza virus infection induces degradation of Pol II
Our group reported previously that the inﬂuenza virus RNA
polymerase complex binds to the CTD of the serine-5 phosphorylated
form of Pol II at 3 h post infection (Engelhardt et al., 2005). The CTD of
Pol II represents a landing pad for numerous host factors involved in
host mRNA processing (Hirose and Manley, 2000; Howe, 2002;
Proudfoot et al., 2002) and we hypothesized that its association with
the viral RNA polymerase could affect Pol II function. To address this,
we infected human 293T cells with inﬂuenza A/WSN/33 virus,Fig. 1. The large subunit of Pol II is speciﬁcally degraded in cells infected with inﬂuenza
virus. 293T cells were infected with inﬂuenza A/WSN/33 virus or were mock-infected
(M). Cell lysates were prepared at the indicated time points post infection and analyzed
by Western blotting. The antibodies used to detect the non-phosphorylated (Pol IIa)
and phosphorylated (Pol IIo) forms of Pol II, serine-5 phosphorylated Pol II (Pol II pS-5),
serine-2 phosphorylated Pol II (Pol II pS-2), the RPC32 and RPC39 subunits of Pol III, β-
actin, and the viral RNA polymerase subunit PA are speciﬁed in the Materials and
methods section. The identity of bands is indicated on the right. Size markers in kDa are
indicated on the left.harvested cells at 3, 6, 9, and 12 h post infection, and analyzed Pol II by
Western blot using an antibody recognizing both the non-phosphor-
ylated transcriptionally unengaged (Pol IIa) and the phosphorylated
transcriptionally engaged (Pol IIo) forms of Pol II (Fig. 1). We found a
signiﬁcant reduction in both forms of Pol II at late points post
infection. In particular, we observed a reduction in the Pol IIo form
from 6 h post infection. In comparison, there was a slight delay in the
reduction of the Pol IIa form with a clear reduction from 9 h post
infection.
Next we analyzed the same cell lysates with antibodies that
speciﬁcally recognize the serine-2 and serine-5 phosphorylated forms
of Pol II. Serine-5 phosphorylation of the CTD is characteristic of the
initiating form of Pol II, engaged in capping, while serine-2
phosphorylation is prevalent in the CTD of the elongating form of
Pol II (Palancade and Bensaude, 2003). We found a clear reduction in
both the initiating and elongating forms from 6 h post infection with a
more pronounced effect on the elongating form (Fig. 1). We have also
analyzed β-actin and two different subunits of host RNA polymerase
III, RPC32 and RPC39, none of which showed any detectable reduction
(Fig. 1), suggesting that the effect on Pol II was not due to a general
proteolytic degradation of host proteins in inﬂuenza virus infected
cells. A Western blot analysis of the PA subunit of the inﬂuenza virus
RNA polymerase complex conﬁrmed that the cells were infected
(Fig. 1). Taking into account that the half-life of the large subunit ofFig. 2. Analysis of the association of Pol II and Pol III with promoter DNA during the viral
life cycle by using ChIP. ChIP was performed using lysates from 293T cells either mock-
infected (M) or infected with inﬂuenza A/WSN/33 virus for the indicated periods of
time and antibodies against Pol II (N-20) or Pol III (C32-3). Quantitation was performed
by real-time PCR using primers speciﬁc for the promoter region of the β-actin, DHFR, or
7SK RNA genes as described (Chan et al., 2006). Polymerase densities were expressed
relative to the mock sample which was set to 1. An average of data from two
independent experiments is shown with range.
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2007) (Chan and Fodor, unpublished), these results show that there is
a speciﬁc degradation of the large subunit of Pol II at late points post
infection in cells infected with inﬂuenza virus.
Viral infection results in the reduction of Pol II engaged at the
promoter region of Pol II genes
Previously, our group reported that inﬂuenza virus infection
inhibits Pol II elongation (Chan et al., 2006). In particular, it was
found that there was a signiﬁcant reduction in Pol II densities in the
coding, but not the promoter region, of the DHFR and β-actin genes in
inﬂuenza virus infected cells compared to mock-infected cells at 3 h
post infection. Having observed that the large subunit of Pol II is
degraded in infected cells, we performed a chromatin immunopre-
cipitation (ChIP) assay to examine the densities of Pol II at the
promoter region of the DHFR and β-actin genes during the viral life
cycle (Fig. 2). We found no change in Pol II associated with the β-actin
promoter at 3 h post infection. In contrast, at 6, 9, and 12 h post
infection, there was a reduction. Interestingly, for the DHFR promoter
we observed a transient increase in Pol II at 3 h post infection,
followed by its gradual reduction at later time points. These results are
consistent with the observations above that Pol II is degraded in
inﬂuenza virus infected cells at late points post infection. As a control,
we have also analyzed the association of Pol III with the 7SK RNA
promoter (Fig. 2). We found no effect at 3 h post infection although at
the 6 h time point there was an apparent reduction. However, in
contrast to Pol II, no further reduction was observed at 9 and 12 h
suggesting that inﬂuenza virus might affect Pol II and Pol III function
differentially.
Mechanism of Pol II degradation in inﬂuenza virus infected cells
Having determined that the large subunit of Pol II is speciﬁcally
degraded in inﬂuenza virus infected cells, resulting in the decrease of
transcriptionally engaged initiating Pol II at the promoter region of Pol
II genes, we were interested in establishing the molecular mechan-
isms of Pol II degradation. Interestingly, overexposure of Western blotFig. 3. Ubiquitylation of the large subunit of Pol II increases during the viral life cycle.
(A) Overexposure of the serine-5 phosphorylated form of Pol II (detected with the H14
antibody) frommock (M) or inﬂuenza A/WSN/33 virus infected cells (harvested at the
indicated time points post infection). High molecular weight bands recognized by the
Pol II-speciﬁc antibody, apparent at the 6-12 h time points, are indicated by “?”. (B)
Immunoprecipitation of ubiquitin from lysates of mock or virus infected cells. Input
samples (upper panel) and immunoprecipitates with (middle panel) or without (lower
panel) ubiquitin-speciﬁc antibody were analyzed byWestern blot using the H14 serine-
5-speciﬁc Pol II antibody.analyses of the initiating form of Pol II from inﬂuenza virus infected
cells revealed high molecular weight Pol II-speciﬁc signals at late
points post infection (Fig. 3A). These results suggested that Pol II could
be a substrate for secondary modiﬁcations, i.e. ubiquitylation, leading
to an increase in its molecular weight. To test this hypothesis, we
performed immunoprecipitation of inﬂuenza virus infected cell
lysates with a ubiquitin-speciﬁc antibody (Fig. 3B). Western blot
analysis of the immunoprecipitates with a Pol II-speciﬁc antibody
showed that increasing amounts of the ubiquitylated initiating form
of the large subunit of Pol II were present late in infection. Taken
together, these results suggest that inﬂuenza virus infection results in
an increase in the ubiquitylation of Pol II or, alternatively, Pol II is
present in complexes containing ubiquitylated proteins. However, the
observed increase in themobility of the large subunit of Pol II (Fig. 3A)
suggests that the large subunit itself is a substrate for ubiquitylation.
Thus, inﬂuenza virus infection results in Pol II ubiquitylation possibly
leading to its degradation by the proteasome pathway.
The role of the viral RNA polymerase in the degradation of Pol II
Next we asked the question whether the binding of the trimeric
inﬂuenza virus RNA polymerase complex to the CTD of the large
subunit of Pol II plays a role in triggering Pol II degradation in virus
infected cells. We hypothesized that binding of the viral RNA
polymerase complex to the CTD of the initiating form of Pol II could
lead to Pol II pausing or arrest. This would trigger mechanisms
analogous to those observed during DNA damage or in cells treated
with α-amanitin when Pol II arrest is followed by the recruitment of
the proteasome to Pol II leading to its ubiquitylation and degradation
(Ratner et al., 1998; Somesh et al., 2005; Yang et al., 2003). We
transfected 293T cells with plasmids expressing the PB1, PB2, and PA
subunits of the viral RNA polymerase complex or performed
transfections with a control plasmid (Fig. 4). When all three subunits
were co-expressed, we observed a decrease in the non-phosphory-
lated unengaged (Pol IIa) and an increase in the phosphorylated
transcriptionally engaged (Pol IIo) forms of Pol II. Western blot
analysis of the serine-5 phosphorylated form of Pol II conﬁrmed that
at least some of the increased Pol IIo signal was due to the
accumulation of the initiating form (Fig. 4). Interestingly, we also
observed a decrease in the non-phosphorylated form in cells
expressing the PA subunit alone, suggesting that the overexpression
of PA is sufﬁcient to induce the degradation of the non-phosphory-
lated form of Pol II. However, PA failed to induce an accumulation of
the phosphorylated form, including the serine-5 phosphorylated
form. Neither the expression of PB1 alone nor PB2 alone had a
detectable effect on any of the Pol II forms (Fig. 4). Taken together,
these results support the hypothesis that binding of the trimeric viral
RNA polymerase to the CTD of Pol II induces Pol II arrest and its
transient accumulation in a transcriptionally engaged form. This could
result in the depletion of the transcriptionally unengaged form of Pol
II as observed in cells expressing all three RNA polymerase subunits.
However, the observation that the expression of the PA subunit alone
can result in the decrease of the non-phosphorylated form of Pol II
suggests that free PA, not associated with PB1 and PB2, could
contribute to the depletion of the transcriptionally unengaged form
of Pol II.
In order to investigate whether the binding of the trimeric viral
RNA polymerase to Pol II is a prerequisite for the accumulation of the
transcriptionally engaged from, we took advantage of a PB2 mutant
with reduced Pol II binding activity in the context of the trimeric viral
RNA polymerase complex. This mutant, F363A, originally identiﬁed as
a mutant deﬁcient in cap-binding (Fechter et al., 2003) and
subsequently found to have reduced Pol II-binding activity (Loucaides
et al., 2009), showed a reduced induction of the accumulation of the
transcriptionally engaged Pol IIo form (Figs. 5A and B). The serine-5
phosphorylated form of Pol II was not affected by the expression of
Fig. 4. Expression of the trimeric viral RNA polymerase complex results in the accumulation of the initiating form of Pol II. (A)Western blot analysis of Pol II in lysates from 293T cells
expressing the viral RNA polymerase trimer (3P) or the individual polymerase subunits PB1, PB2, or PA, or expressing no viral polymerase proteins (Control). Pol II was analyzedwith
the N-20 (Pol IIa and Pol IIo) or H14 (Pol II pS-5) antibodies. RanBP5 was detected as a loading control. The presence of the viral polymerase subunits was conﬁrmed byWestern blot
analysis using antibodies speciﬁc for the individual polymerase subunits. The identity of bands is indicated on the right. Size markers in kDa are indicated on the left. (B) Quantitation
of Western blots from panel A. Polymerase intensities were expressed as a percentage of intensities observed in the mock-transfected sample (Control) which was set to 100%. Two
independent transfections were performed and each sample was analyzed twice byWestern blot. The results shown, derived from fourWestern blot analyses, represent the average
of two independent experiments with range indicated.
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mutant, F404A (Fechter et al., 2003), that retains wild-type levels of
Pol II binding (Loucaides et al., 2009), induced a similar increase in Pol
IIo, including the serine-5 phosphorylated form, as the wild-type
trimeric RNA polymerase. Co-expression of PB1 and PA in the absence
of PB2 (2P) resulted in no detectable effect on the Pol IIo and serine-5
phosphorylated forms of Pol II. In all cases when viral RNA polymerase
subunits were expressed, a reduction in the Pol IIa formwas observed,
presumably due to the expression of the PA subunit. The Pol II-binding
properties of the PB2 mutant polymerase complexes were conﬁrmed
by immunoprecipitation with a PA-speciﬁc antibody (Fig. 5C). Further
immunoprecipitation experiments with an antibody speciﬁc for
ubiquitin followed by Western blot analysis of the immunoprecipi-
tates for Pol II showed that the accumulated serine-5 phosphorylated
form of Pol II is ubiquitylated (Fig. 5C). Taken together, these results
show that the accumulation of the ubiquitylated serine-5 phosphor-
ylated form of Pol II is dependent on the binding of the viral RNA
polymerase.
Expression of the viral RNA polymerase results in the inhibition of Pol II
transcription
Our group previously demonstrated that Pol II elongation is
inhibited in cells infected with inﬂuenza virus (Chan et al., 2006). The
results described above suggest that this could be due to Pol II arrest
induced by the viral trimeric RNA polymerase binding to the initiating
Pol II and/or to PA targeting the non-engaged form of Pol II for
degradation. To address whether the expression of the viral RNA
polymerase complex inhibits Pol II transcription, we used an IFN-
inducible luciferase reporter gene system (Didcock et al., 1999). We
transfected 293T cells with a combination of plasmids to express the
viral RNA polymerase subunits and a luciferase reporter and treated
the cells with interferon. Cell lysates were analyzed for luciferase
activity (Fig. 6A). IFN treatment resulted in a strong induction of
luciferase activity [compare Control (+) to Control (−)]. The
expression of individual PA or the trimeric polymerase complex
resulted in a statistically signiﬁcant (as assessed by a Student's t test)
reduction in reporter gene activity, while the expression of individual
PB1 or PB2 had no effect (Fig. 6A, left panel). In order to determine
whether the binding of the trimeric RNA polymerase complex to theserine-5 phosphorylated form of Pol II contributes to the reduction,
we used the PB2 F363A and F404A mutants described above (Fig. 6A,
right panel). We observed a statistically signiﬁcant reduction in
reporter levels for both mutants although the reduction was less
pronounced in the case of the F363A mutant suggesting that binding
to Pol II might play a role. Neither of the individual PB2 mutants had a
detectable effect on reporter levels.
We also analyzed the effect of the expression of the inﬂuenza virus
RNA polymerase on an endogenous gene by taking advantage of the
interferon-inducible ISG15 gene (Sadler and Williams, 2008). We
transfected 293T cells with a combination of plasmids to express the
viral RNA polymerase subunits as above and treated the cells with
interferon to induce the ISG15 gene. We isolated total RNA and
analyzed the levels of ISG15 mRNA by using quantitative RT-PCR (Fig.
6B). IFN treatment resulted in a relatively modest increase in the
ISG15 mRNA. Neither the expression of PB1 alone nor PB2 alone
affected the expression of the ISG15 mRNA. However, we found a
statistically signiﬁcant reduction in ISG15 mRNA expression when
individual PA or all three RNA polymerase subunits (3P WT) were
expressed. In contrast, we observed no statistically signiﬁcant
reduction in ISG15mRNA levels when the wild-type PB2was replaced
with the F363A mutant that reduces the binding of the trimeric RNA
polymerase to Pol II. The PB2 mutant with the F404A mutation that
binds Pol II similar to the wild-type, inhibited ISG15mRNA expression
to the same level as the wild-type polymerase complex. The presence
of PB2 was important for the inhibition of ISG15 mRNA expression as
the PB1-PA dimer had no signiﬁcant effect.
Taking the results from the two assays together, we conclude that
the expression of individual PA or the trimeric viral RNA polymerase
complex results in the inhibition of Pol II activity. The ability of the
trimeric complex to inhibit Pol II appears to be affected by its Pol II-
binding activity suggesting that the association between the viral and
host transcriptional machineries is an important factor in the
observed Pol II inhibition.
Effect of Pol II inhibition and degradation on the regulation of viral RNA
transcription and replication
Our results show that Pol II is inhibited and degraded in cells
infected with inﬂuenza virus. However, inﬂuenza virus mRNA
Fig. 5. Binding of the trimeric viral RNA polymerase to Pol II is required for the induction of the accumulation of the initiating form of Pol II. (A)Western blot analysis of Pol II in lysates
from transfected 293T cells expressing the viral RNA polymerase trimer [wild type (3P WT) or mutants with mutations in the PB2 subunit (3P F363A or 3P F404A)], a PB1-PA
polymerase dimer (2P), or expressing no viral polymerase proteins (Control). Pol II was analyzed with the N-20 (Pol IIa and Pol IIo) or H14 (Pol II pS-5) antibodies. RanBP5 was
detected as a loading control. The presence of the viral polymerase subunits was conﬁrmed byWestern blot analysis using antibodies speciﬁc for the individual polymerase subunits.
(B) Quantitation of Western blots from panel A. Polymerase intensities were expressed as a percentage of intensities observed in the mock-transfected sample (Control) which was
set to 100%. Two independent transfections were performed and each sample was analyzed twice by Western blot. The results shown, derived from four Western blot analyses,
represent the average of two independent experiments with range indicated. (C) Immunoprecipitation of PA (upper panels) or ubiquitin (lower panels) from lysates of mock or virus
infected cells. Immunoprecipitates with [(+) ab.] or without [(−) ab.] speciﬁc antibody were analyzed by Western blot using the H14 serine-5-speciﬁc Pol II antibody.
Immunoprecipitates obtained with the PA antibody were also analyzed for the presence of the polymerase subunits PB1, PB2, and PA using speciﬁc polyclonal antibodies. Note the
reduced levels of PB1 co-immunoprecipitating with PA in the absence of PB2 (2P).
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primed by capped RNA fragments derived from host mRNAs (Bouloy
et al., 1978; Krug et al., 1979). The splicing of viral mRNAs and their
nuclear export might also be dependent on active Pol II (Amorim and
Digard, 2006; Amorim et al., 2007; Bouloy et al., 1978; Engelhardt and
Fodor, 2006; Krug et al., 1979). How can one reconcile these
apparently contradictory processes? How does the inhibition/degra-
dation of Pol II affect the regulation of viral transcription and
replication?
In order to address these questions, we investigated the accumu-
lation of viral RNAs in infected cells at various times post infection.We
infected 293T cells with inﬂuenza A/WSN/33 virus, isolated total RNA
from infected cells at 3, 4.5, 6, and 9 h post infection, and analyzed
viral RNA levels by a primer extension assay (Fig. 7A). Our results
show that while maximal mRNA accumulation occurs relatively early
during the replication cycle (between 3 and 4.5 h), vRNA synthesis
continues late in infection (Fig. 7B). These results are in agreementwith numerous previous studies reporting an early peak in mRNA
synthesis, followed by exclusive vRNA synthesis late in infection
(Hatada et al., 1989; Lee and Seong, 1998; Shapiro et al., 1987).
Although several hypotheses have been put forward to explain this
phenomenon (Perez and Donis, 1998; Watanabe et al., 1996; Ye et al.,
1989; Zvonarjev and Ghendon, 1980), often referred to as a “switch”
from transcription to replication, the precise molecular mechanisms
involved remain unknown.
Our group proposed that viral mRNA synthesis requires the
association observed between the viral RNA polymerase and Pol II
as it might allow the viral transcriptional machinery to access the cap
structure of nascent RNAs as well as RNA processing factors
(Engelhardt et al., 2005). In order to investigate this association
during the viral life cycle, we performed immunoprecipitations of the
viral RNA polymerase using a PA-speciﬁc antibody and analyzed the
immunoprecipitates for the presence of the initiating form of Pol II by
using Western blotting (Fig. 7C). We observed that a maximal
Fig. 6. Expression of the RNA polymerase results in the inhibition of Pol II transcription. (A) Effect of viral RNA polymerase on IFN-inducible luciferase reporter gene expression. 293T
cells were transfected with plasmids to express the indicated viral RNA polymerase subunits individually or in combination (see legend to Fig. 5 for details) and an IFN-inducible
luciferase reporter plasmid. Luciferase expression was induced by IFN treatment and expression levels were determined by a luciferase assay. Luciferase levels in induced cells [Cntrl
(+)] were set to 1. Cntrl (−), uninduced cells. Data presented are an average from 4 independent transfections, with standard deviations shown. (B) Effect of viral RNA polymerase
on the IFN-inducible endogenous ISG15 gene. Transcription of the ISG15 gene was induced by IFN treatment and ISG15 mRNA levels quantitated by RT-PCR. mRNA levels in induced
cells not expressing RNA polymerase subunits [Cntrl (+)] were set to 1. Cntrl (−), uninduced cells. Data presented are an average from 6 independent transfections with standard
deviations shown. Two-tailed unpaired Student's t tests were performed to assess whether the values in the presence of RNA polymerase were signiﬁcantly different from the values
in their absence. The numbers shown above the bars represent the p values in comparison with Cntrl (+).
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post infection. At later time points, a much reduced association was
observed. We also performed a ChIP assay of the association of the
viral RNA polymerase with Pol II promoter DNA (Fig. 7D). We found
maximal association with the β-actin promoter at 3 h post infection
with dramatically reduced values at the later time points. Similar
results were observed using the DHFR gene. The observation that the
maximal association between the viral RNA polymerase and Pol II
approximately coincides with the maximal viral mRNA accumulation
suggests that the two processes might be linked providing support for
the hypothesis that an association between the viral RNA polymerase
and Pol II is required for viral transcription. These results also suggest
that the dramatic downturn in mRNA synthesis that occurs at
approximately 4.5 h post infection could be the result of the
inhibition/degradation of Pol II induced by the accumulating levels
of the viral RNA polymerase in infected cells.
Discussion
In this paper, we show that the large subunit of Pol II is degraded in
293T cells infected with inﬂuenza A/WSN/33 virus. Degradation of
Pol II was also observed in HeLa cells infected with A/WSN/33
(H1N1) (Chan and Fodor, unpublished), MDCK cells infected with
SC35 or SC35M viruses (H7N7) (Gabriel and Fodor, unpublished), and
293T, COS-1, HeLa, and NLB2 cells infectedwith A/WSN/33 (H1N1) or
A/Victoria/3/75 (H3N2) (Rodriguez et al., 2007), suggesting that Pol
II degradation is a general phenomenon that can be induced by
various subtypes of inﬂuenza virus. There is an increasing body of
evidence that viruses have developed a multitude of strategies to
inhibit host gene expression (Lyles, 2000). A general inhibition of host
gene expression is likely to represent an efﬁcient mechanism to
suppress the activation of innate immune responses that are
inevitably activated upon viral infection as a consequence of theexpression of a variety of viral factors (e.g. 5′pppRNA, dsRNA) that are
recognized by the host cell as foreign (Garcia-Sastre and Biron, 2006;
Pichlmair and Reis e Sousa, 2007). Thus, inﬂuenza virus-induced Pol II
degradation could represent a novel mechanism of inhibiting antiviral
host responses.
How could inﬂuenza virus infection lead to the degradation of the
large subunit of Pol II? We observed degradation of both the non-
phosphorylated and phosphorylated forms of the large subunit of Pol
II and there was a particularly severe decrease in the elongating
(serine-2 phosphorylated) form from 6 h post infection. During viral
infection, we detected the accumulation of Pol II forms recognized by
an antibody speciﬁc for the serine-5 phosphorylated form that
migrated at a higher than expected molecular weight. These results
suggested that Pol II might be ubiquitylated and indeed, an
immunoprecipitation using a ubiquitin-speciﬁc antibody, resulted in
the detection of increased levels of ubiquitylated Pol II in infected
cells. Ubiquitylation often targets proteins for degradation via the
proteasome pathway (Weissman, 2001) suggesting that the protea-
some might be involved in the degradation of Pol II. We attempted to
use proteasome inhibitors (e.g. MG132, lactacystin) to investigate
whether Pol II degradation could be prevented in inﬂuenza virus
infected cells. Although we observed a delay in the degradation of Pol
II, these results were inconclusive as the proteasome inhibitors also
resulted in a delay in viral infection (Chan and Fodor, unpublished).
How is ubiquitylation of Pol II triggered in inﬂuenza virus infected
cells? We speculate that binding of the viral RNA polymerase to the
CTD of the initiating form of Pol II could trigger mechanisms that are
known to be activated during DNA damage. DNA damage results in
the arrest of Pol II at the DNA lesion often leading to the clearance of
arrested Pol II by its degradation via ubiquitylation (Ratner et al.,
1998; Somesh et al., 2005; Yang et al., 2003). Indeed, ChIP data show
an increased association of Pol II with the DHFR promoter which is
consistent with the idea of Pol II arrest. Upon the co-expression of the
Fig. 7. Shutdown of viral mRNA synthesis coincides with the degradation of Pol II. (A) Primer extension analysis of viral RNA levels in mock (M) and inﬂuenza A/WSN/33 virus
infected 293T cells at the indicated time points post infection. The positions of viral mRNA, cRNA, and vRNA are indicated on the right. 5S rRNA was used as an internal control. Size
markers in nucleotides are shown on the left. (B) Quantitation of RNA levels from panel A by phosphorimage analysis. (C) Immunoprecipitation of the viral RNA polymerase with a
PA-speciﬁc antibody from lysates of mock (M) or virus infected cells. Input samples (upper panel, as shown in Fig. 1.) and immunoprecipitates (IP, lower panel) were analyzed with
the H14 Pol II-speciﬁc antibody. (D) Analysis of the association of the viral RNA polymerase with Pol II promoter DNA during the viral life cycle by using ChIP. ChIP was performed
using lysates from 293T cells either mock-infected or infected with inﬂuenza A/WSN/33 virus for the indicated periods of time and antibodies against the PA subunit of the RNA
polymerase complex. Quantitation was performed by real-time PCR using primers speciﬁc for the promoter region of the β-actin or DHFR genes as described (Chan et al., 2006). Viral
RNA polymerase densities were expressed relative to the sample isolated at 3 h post infection (maximal detected association) which was set to 1. An average of the data from two
independent experiments is shown with range.
131F.T. Vreede et al. / Virology 396 (2010) 125–134three subunits of the viral RNA polymerase complex, an accumulation
of the serine-5 phosphorylated form of Pol II was also observed in the
absence of viral infection. These results lend support to the hypothesis
that transcriptional arrest triggered by the binding of the viral RNA
polymerase to the initiating form of Pol II might be responsible for Pol
II ubiquitylation.
Recently, Rodriguez et al. (2007) proposed that the proteolytic
activity of the PA subunit of the viral RNA polymerase could be
responsible for the degradation of Pol II in inﬂuenza virus infected
cells. In particular, they showed that infection with a recombinant
virus encoding a PA point mutant with reduced proteolytic activity
resulted in a transient delay in the degradation of the hypopho-
sphorylated from of Pol II. They also showed that the levels of
hypophosphorylated Pol II were decreased in cells expressing the
three subunits of the viral RNA polymerase, while expression of PA
alone had no effect on Pol II levels. We conﬁrmed that the levels of
the non-phosphorylated form of Pol II were reduced upon the co-
expression of the three viral RNA polymerase subunits, but
surprisingly, overexpression of the single subunit PA resulted in a
similar reduction of the non-phosphorylated form of Pol II. Thus, two
mechanisms might operate during viral infection that could result in
Pol II degradation: on one hand, individual PA, not complexed with
PB1 and PB2, could induce the degradation of free unengaged form of
Pol II; on the other hand, the trimeric polymerase complex by
binding to the initiating form of Pol II induces its arrest and
ubiquitylation that eventually lead to proteasome-mediated degra-dation. However, in virus infected cells, as opposed to transfected
cells expressing PA alone, most of PA is likely to be present in
complex with PB1 and PB2. Therefore, during viral infection, Pol II
degradation induced by PA might not play a signiﬁcant role and most
Pol II degradation could be the consequence of Pol II inhibition
induced by the binding of the trimeric viral RNA polymerase complex
to the initiating form of Pol II.
We cannot, however, exclude the possibility that the proteolytic
activity of PA also plays a role in inducing Pol II degradation in the
context of the RNA polymerase trimer. It is possible that the
association of PA with PB1 in the absence of wild-type PB2 (2P) or
presence of a mutant PB2 (PB2 F363A) leads to a conformational
change in PA that results in the inhibition of its proteolytic activity.
Moreover, it should be noted that, in contrast to viral infections, no
decrease in the transcriptionally engaged form of Pol II was detected
in cells expressing the viral RNA polymerase subunits during the
course of the experiment (up to 24 h post transfection) although the
non-phosphorylated unengaged form was reduced. This suggests
that for triggering degradation of the transcriptionally engaged form
of Pol II, a viral factor not present in the transfected cells is required.
We can only speculate that cleavage of the nascent host transcript by
the viral RNA polymerase that is dependent on the presence of vRNA
(Hagen et al., 1994) might be needed for the triggering of Pol II
degradation. Removal of the 5′ cap structure of the nascent host
transcript by the endonucleolytic activity of the viral RNA polymer-
ase would lead to the exposure of the 5′ end of the transcript. Such
132 F.T. Vreede et al. / Virology 396 (2010) 125–134transcript could be attacked by host nucleases, i.e. Xrn2, that play a
role in the termination of Pol II after cleavage of the nascent
transcript downstream of the poly(A) signal (West et al., 2004). We
have attempted to address this question by reconstituting recombi-
nant RNPs in 293T cells by transfecting plasmids to express the viral
RNA polymerase subunits, NP, and a vRNA. However, we observed no
reduction in the engaged form of Pol II possibly due to the low
percentage of cells expressing functional RNPs (results not shown).
Clearly, further studies are required to fully understand the
molecular mechanisms of Pol II degradation in inﬂuenza virus
infected cells.
Irrespective of the exact molecular mechanism, inﬂuenza virus-
induced Pol II degradation inevitably affects the regulation of viral
RNA synthesis. Previous studies suggested that inﬂuenza virus has
developed a mechanism to regulate the synthesis of its own RNAs
such that during the early stages viral mRNA is synthesized to allow
viral protein production, while late in infection vRNA synthesis
dominates to ensure sufﬁcient levels of vRNA for the assembly of
progeny virions (Shapiro et al., 1987). We conﬁrmed previous results
that viral mRNA synthesis peaks early during viral infection, while
vRNA synthesis continues late in infection. However, our results
suggest that the dramatic shut-off of viral mRNA synthesis late in
infection might be the result of reduced interaction between the viral
and host transcriptional machineries due to Pol II degradation. We
found that maximal association between the viral RNA polymerase
and Pol II occurred at about 3 h post infection, close to the time of
maximal viral mRNA production. As infection proceeds, Pol II is
degraded which results in the reduction of the association of the viral
RNA polymerase with the Pol II transcriptional machinery as shown
by co-immunoprecipitations and ChIP assay (see Fig. 7). In conclusion,
we propose that the degradation of the large subunit of Pol II could be
the cause for the reduction in viral mRNA synthesis late in infection.
This contrasts themodel by Rodriguez et al. (2007)who proposed that
the degradation of the hypophosphorylated form of Pol II correlates
with the onset of viral transcription.
We showed in this study that, in the presence of the PA subunit
and the trimeric RNA polymerase complex that binds to Pol II, the
expression of IFN-stimulated Pol II genes is inhibited, suggesting that
Pol II inhibition induced by the viral RNA polymerase could play a role
in the suppression of antiviral host responses. Another mechanism,
proposed for inhibiting host gene expression and antiviral host
responses involves the viral non-structural protein 1 (NS1) (Hale et
al., 2008). NS1 was shown to interfere with host gene expression by
inhibiting host mRNA polyadenylation via interactions with the 30-
kDa subunit of the host cleavage and polyadenylation factor (CPSF30)
and nuclear poly(A)-binding protein (PABII) (Chen et al., 1999;
Nemeroff et al., 1998). More recently, the viral RNA polymerase has
been proposed to form an integral component of the CPSF30-NS1
protein complex (Kuo and Krug, 2009). Thus, inﬂuenza virus might
have developed a complex mechanism leading to host shut-off
involving multiple viral components.
In summary, our ﬁndings suggest a novel mechanism for the
inhibition of host gene expression in inﬂuenza virus infected cells. The
viral RNA polymerase might play a crucial role in this mechanism by
hijacking the host Pol II transcriptional machinery, eventually leading
to the degradation of the large subunit of Pol II. Inhibition and
degradation of Pol II will inevitably affect the expression of genes
involved in antiviral host responses and therefore the pathogenicity of
inﬂuenza viruses. While this study was under review, Rodriguez et al.
(2009) provided experimental evidence that attenuated strains of
inﬂuenza A viruses do not induce degradation of Pol II and proposed
that the ability of inﬂuenza viruses to inhibit and degrade Pol II might
contribute to their virulence. It remains to be determined to what
extent RNA polymerases from various inﬂuenza virus strains,
including highly pathogenic H5N1 viruses, differ in their ability to
trigger Pol II inhibition and degradation.Materials and methods
Cells and virus
Human embryonic kidney (293T) cells were obtained from the Cell
Bank of the Sir William Dunn School of Pathology. Cells were cultured
in minimum essential medium (MEM) supplemented with 10 % fetal
calf serum (FCS) and 2 mM L-glutamine. Inﬂuenza A/WSN/33 virus
was a gift from Dr. P. Palese (Mount Sinai School of Medicine, New
York).
Infections, transfections, and Western blot analyses
Infections were performed in 293T cells using inﬂuenza A/WSN/
33 virus at an MOI of 4. Transfections were performed in 293T cells
using Lipofectamine 2000 (Invitrogen) and plasmids encoding the
RNA polymerase subunits of inﬂuenza A/WSN/33 virus (pCAGGS-
PB1, pCAGGS-PB2, and pCAGGS-PA; gift of Dr. A. García-Sastre, Mount
Sinai School of Medicine, New York). The F363A or F404A mutants of
pCAGGS-PB2 were generated by site directed mutagenesis. Lysates
from infected or transfected cells were analyzed by Western blotting
using antibodies to detect the large subunit of Pol II (N-20, Santa
Cruz), serine-5 phosphorylated CTD (H14, Covance), serine-2 phos-
phorylated CTD (H5, Covance), Pol III subunits RPC32 (clone C32-3)
and RPC39 (clone C39-2) (Jones et al., 2000), karyopherin β3 (also
known as RanBP5) (H-300, Santa Cruz), β-actin (Abcam), and the PB1,
PB2, and PA viral RNA polymerase subunits (Carr et al., 2006; Deng et
al., 2005). Signals were generated by using ECL reagent (Amersham or
Millipore) and detected with a LAS4000 imager (Fuji) or by
autoradiography. Images were quantitated using Aida and the results
shown are an average of two independent experiments with range
shown.
Chromatin immunoprecipitation (ChIP)
ChIP was performed using a rabbit polyclonal PA antibody (gift of
Dr. T. Toyoda, Shanghai Pasteur Health Research Foundation), a Pol II
antibody (N-20, Santa Cruz), or a Pol III antibody (C32-3) (Jones et al.,
2000) and lysates from 293T cells infected with inﬂuenza A/WSN/33
virus at an MOI of 4 as described (Chan et al., 2006). Mock-infected
cell lysates and ChIP without a speciﬁc antibody served as negative
controls. Quantitation was performed by real-time PCR using primers
speciﬁc for the promoter region of the β-actin, DHFR, or 7SK RNA
genes as described (Chan et al., 2006). Each experiment was
performed twice and an average of the two experiments with range
is shown.
Immunoprecipitation assays
293T cells were infected with inﬂuenza A/WSN/33 virus at anMOI
of 4, mock-infected, or transfected with the indicated combination of
plasmids. Infected or transfected cells were harvested and resus-
pended in cell lysis buffer (50 mM Tris–HCl, pH 8.0, 200 mM NaCl,
1 mM MgCl2, 0.5% Igepal CA-630, 1 mM DTT, 25% glycerol, one
Complete Mini EDTA-free protease inhibitor cocktail tablet (Roche)/
10 ml) containing Benzonase nuclease (Novagen) (1 U/μl) and
incubated for 1 h at 4 °C. Immunoprecipitations were performed using
protein A-Sepharose CL-4B (Amersham) and antibodies against the
PA subunit of the RNA polymerase (Dr T Toyoda) or ubiquitin
(Abcam). Bound proteins were released by heating samples at 100 °C
for 5 min in SDS-PAGE loading buffer.
Pol II activity assay
In order to investigate Pol II activity in the presence of viral RNA
polymerase, two assays (one employing a reporter gene and the other
133F.T. Vreede et al. / Virology 396 (2010) 125–134analyzing an endogenous gene) were used. In both assays, 293T cells
were transfected with plasmids to express wild-type or mutant RNA
polymerase subunits in different combinations, together with an
interferon-responsive luciferase reporter plasmid [p(9-27)4tkΔ(-39)
lucter kindly provided by Dr. R. Randall, University of St Andrews], as
required. Twenty-four hours post-transfection, cells were treated
with 1000 U/ml cell culture medium of Interferon-αA/D (Sigma) for
4 h. Luciferase expression was measured using a luciferase assay
system (Promega) according to the manufacturer's instructions and a
TriStar LB941 luminometer (Berthold Technologies). For the analysis
of the endogenous gene, following interferon treatment total RNAwas
isolated using Trizol (Invitrogen) and mRNAs were reverse tran-
scribed using a T20 primer and SuperScript II reverse transcriptase
(Invitrogen). ISG15 cDNAs were quantitated by using real-time PCR
and the following primers: 5′-GAAGGCGCAGATCACCCA-3′ and 5′-
CTGCTGCGGCCCTTGTTA-3′. PCR was performed with the QuantiTect
SYBR Green PCR Kit (Qiagen) and a Corbett Rotor-Gene RG-3000
cycler. Reactions were set up in triplicate, and data were analyzed by
using the Comparative Analysis function of the Rotor-Gene 6 software.
Analysis of viral RNAs by primer extension assay
293T cells were infectedwith inﬂuenza A/WSN/33 virus at anMOI
of 4 or were mock-infected. Total RNA was isolated by using Trizol
(Invitrogen) and primer extension analysis of the NA-speciﬁc viral
RNAs was performed as described (Fodor et al., 2002; Vreede et al.,
2004). Primer extension products were analyzed by polyacrylamide
gel electrophoresis, detected by autoradiography, and quantitated by
using a Fuji phosphorimager.
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